A fixed combination of thyme and primula dry extracts normalizes goblet cell hyperplasia and MUC5AC formation in vivo and in vitro

Jan Seibel (Neumarkt i.d.OPf., Germany), Jan Seibel, Aldo Ammendola, Martin Lehner

Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Session: Novel mechanisms and treatment modalities in asthma
Session type: Poster Discussion
Number: 4895
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jan Seibel (Neumarkt i.d.OPf., Germany), Jan Seibel, Aldo Ammendola, Martin Lehner. A fixed combination of thyme and primula dry extracts normalizes goblet cell hyperplasia and MUC5AC formation in vivo and in vitro. Eur Respir J 2016; 48: Suppl. 60, 4895

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mucus-normalizing activity of a fixed thyme and primula extract combination: Reduction of LPS-induced goblet cell metaplasia and mucin production in vivo
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015


Airway surface dehydration confers susceptibility to allergic airway inflammation in vivo
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

Farm dust extract increases the epithelial barrier function of bronchial epithelial cells
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015

Toxicological and inflammatory effects of electronic cigarette extracts using in vitro and ex vivo lung models
Source: International Congress 2016 – Electronic cigarettes
Year: 2016

Changes in epithelial barrier components E-cadherin, Beta-catenin, EGR with steroid treatment in murine model of asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015


Influence of different asthma treatments on TSLP, foxp3 and ZO-1 proteins reflecting inflammation and epithelial barrier function
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013

Side effects of tacrolimus upon airway epithelial tissue
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Effect of high, medium, and low molecular weight hyaluronan on inflammation and oxidative stress in an in vitro model of human nasal epithelial cells
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015

Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


LATE-BREAKING ABSTRACT: MUC1 downregulation induces corticosteroid resistance in asthma’s in vitro and in vivo models
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016

Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015


Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway, alveoli, and metastatic tumors in murine lung
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Loss of bronchial epithelial E-cadherin results in spontaneous airway remodeling and eosinophilic inflammation and exaggerated responses to house-dust mite
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015

Potential effect of the extract of zataria multiflora and its consituent carvacrol on lung inflammation of sensitized guinea pigs
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

Effect of s-carboxymethylcysteine on mucin production in airway epithelial cells in vitro
Source: Eur Respir J 2005; 26: Suppl. 49, 97s
Year: 2005

Regulation of autophagy in amiodarone induced pulmonary fibrosis
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013

Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

LSC 2014 abstract - Azithromycin lowers mucin production by increasing FOXA2 expression in an IL-13-induced MUC5AC expression model in human bronchial epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014


Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015